Cross-cultural adaptation,reliability and validity testing of the Chinese version of Brain Metastases Symptom Checklist

doi:10.3969/j.issn.1674-8115.2021.12.005

Abstract

Abstract: Objective

·To translate the English version of Brain Metastases Symptom Checklist (BMSC) into Chinese version and test its reliability and validity.

Methods

·The translation and adaption of BMSC for the Chinese population were generated by Brislin translation and back-translation model. From January 2017 to June 2019, a sample of 239 brain metastases patients matched with the inclusion criteria were selected via convenience sampling from the Center for Functional Neurosurgery, Department of Neurosurgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine and Gamma Knife Center, Shandong Provincial Hospital affiliated to Shandong First Medical University. The Cronbach's α coefficient was used to evaluate the internal consistency, and the intra-class correlation coefficient (ICC) was used to determine the retest reliability. The item-related content validity index (ICV) and the scale-level average content validity index (S-CVI/Ave) were applied to assess the content validity of the Chinese version of BMSC. The effective size (ES) was calculated to evaluate the responsiveness of the Chinese version of BMSC, and the minimal clinical important difference (MCID) of the Chinese version of BMSC was evaluated by using anchor-based approach and distribution-based approach respectively.

Results

·The Cronbach's α coefficient of the Chinese version of BMSC was 0.85, and the ICC reflecting retest reliability was 0.72. The I-CVI was 0.8?1.0, and the S-CVI/Ave was 0.97. The scores of the Chinese version of BMSC before and after gamma knife treatment showed significant differences (P<0.05), and the ES of the Chinese version of BMSC was 0.01?0.35. The MCID value of BMSC score obtained by anchor-based method was 0.07?1.28, and the value obtained by distribution-based method was 0.01?0.60.

Conclusion

·The Chinese version of BMSC has good validity and reliability.

Key words: brain metastases, symptom, scale, reliability, validity

CLC Number:

R473.73

Xian QIU, Wei-yi ZHU, Peng ZHAO, Si-jian PAN, Bo-min SUN, Bei-wen WU. Cross-cultural adaptation,reliability and validity testing of the Chinese version of Brain Metastases Symptom Checklist[J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(12): 1573-1578.

Figures/Tables 3

TrendMD

References 17

1	Kaal EC, Niël CG, Vecht CJ. Therapeutic management of brain metastasis[J]. Lancet Neurol, 2005, 4(5): 289-298.
2	赵东海, 杜汉强,王嘉嘉,等. 伽玛刀治疗对脑转移瘤病人认知功能及生活质量影响的研究[J]. 中国微侵袭神经外科杂志, 2020, 25(5): 205-208.
3	Bezjaka A. Adam J, Barton R.et al. Symptom response after palliative radiotherapy for patients with brain metastases[J]. Eur J Cancer, 2002, 38(4): 487-496.
4	Rodin D, Banihashemi B, Wang L, et al. The Brain Metastases Symptom Checklist as a novel tool for symptom measurement in patients with brain metastases undergoing whole-brain radiotherapy[J]. Curr Oncol, 2016, 23(3): e239-e247.
5	孙振球. 医学统计学[M]. 北京: 人民卫生出版社, 2010: 273.
6	Brislin RW. Back-translation for cross-cultural research[J]. J Cross Cult Psychol, 1970, 1(3): 185-216.
7	Hays RD, Hadorn D. Responsiveness to change: an aspect of validity, not a separate dimension[J]. Qual Life Res, 1992, 1(1): 73-75.
8	Revicki D, Hays RD, Cella D, et al. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes[J]. J clin Epidemiol, 2008, 61(2): 102-109.
9	Davis LL. Instrument review: getting the most from a panel of experts[J]. App Nurs Res, 1992, 5:194-197.
10	张方圆, 沈傲梅, 马婷婷,等. 中国癌症症状管理实践指南计划书[J]. 护理研究, 2018, 32(1): 8-12.
11	唐华, 王甦平, 龚睿婕, 等. 挫败感量表对医学生焦虑抑郁态的信效度评估[J]. 上海交通大学学报(医学版), 2019, 39(1): 84-88.
12	Teke F, Bucaktepe P, Kıbrıslı E, et al. Quality of life, psychological burden, and sleep quality in patients with brain metastasis undergoing whole brain radiation therapy[J]. Clin J Oncol Nurs, 2016, 20(5): AE-A2.
13	Good P, Pinkerton R, Bowler S, et al. Impact of opioid therapy on sleep and respiratory patterns in adults with advanced cancer receiving palliative care[J]. J pain Symptom Manage, 2018, 55(3): 962-967.
14	Davidson JR, MacLean AW, Brundage MD, et al. Sleep disturbance in cancer patients[J]. Soc Sci Med, 2002, 54(9): 1309-1321.
15	Willis KD, Ravyts SG, Lanoye A, et al. Sleep disturbance in primary brain tumor: prevalence, risk factors, and patient preferences[J]. Support Care Cancer, 2021. DOI: 10.1007/s00520-021-06476-3.
16	戴海崎, 张锋, 陈雪枫. 心理与教育测量[M]. 广州: 暨南大学出版社, 2008: 59-65.
17	刘砚燕. 患者报告结局测量信息系统:儿童报告版和父母报告版癌症相关简表的测量学研究[D]. 上海: 第二军医大学, 2016.

Item	BMSC score/score			t value	P value	Responsiveness
Item	Before treatment	After treatment	Difference	t value	P value	ES	SRM
1	1.61±2.44	0.82±1.65	-0.77±2.47	0.30	0.00	0.31	0.31
2	2.21±3.00	1.73±2.58	-0.36±2.15	0.71	0.00	0.12	0.17
3	2.69±3.18	2.22±2.93	-0.43±2.80	0.57	0.00	0.13	0.15
4	1.91±2.86	1.57±2.59	-0.27±2.45	0.57	0.00	0.09	0.11
5	1.77±2.48	1.56±2.38	-0.50±2.15	0.63	0.00	0.20	0.23
6	1.17±2.24	0.82±1.89	-0.34±1.94	0.58	0.00	0.13	0.14
7	0.63±1.71	0.39±1.52	-0.11±1.24	0.67	0.00	0.06	0.09
8	2.18±2.50	2.22±2.52	-0.10±1.63	0.79	0.00	0.04	0.06
9	1.72±2.58	1.56±2.44	-0.07±2.11	0.64	0.00	0.02	0.03
10	0.95±1.91	0.54±1.61	-0.40±1.92	0.41	0.00	0.21	0.21
11	0.82±1.88	0.38±1.29	-0.37±1.60	0.51	0.00	0.19	0.23
12	1.70±2.35	1.05±1.87	0.82±2.06	0.57	0.00	0.35	0.40
13	1.82±2.47	1.63±2.31	-0.05±1.99	0.63	0.00	0.02	0.02
14	0.26±0.95	0.32±1.28	0.08±1.09	0.55	0.00	0.08	0.07
15	0.46±1.25	0.43±1.11	-0.02±1.21	0.46	0.00	0.02	0.02
16	2.43±2.81	1.99±2.69	-0.66±2.76	0.53	0.00	0.23	0.24
17	3.71±2.66	3.81±2.73	-0.03±2.51	0.54	0.00	0.01	0.01
18	1.23±2.25	0.83±1.66	-0.11±2.16	0.32	0.00	0.05	0.05

Item	BMSC score/score			t value	P value	Responsiveness
Item	Before treatment	After treatment	Difference	t value	P value	ES	SRM
1	1.61±2.44	0.82±1.65	-0.77±2.47	0.30	0.00	0.31	0.31
2	2.21±3.00	1.73±2.58	-0.36±2.15	0.71	0.00	0.12	0.17
3	2.69±3.18	2.22±2.93	-0.43±2.80	0.57	0.00	0.13	0.15
4	1.91±2.86	1.57±2.59	-0.27±2.45	0.57	0.00	0.09	0.11
5	1.77±2.48	1.56±2.38	-0.50±2.15	0.63	0.00	0.20	0.23
6	1.17±2.24	0.82±1.89	-0.34±1.94	0.58	0.00	0.13	0.14
7	0.63±1.71	0.39±1.52	-0.11±1.24	0.67	0.00	0.06	0.09
8	2.18±2.50	2.22±2.52	-0.10±1.63	0.79	0.00	0.04	0.06
9	1.72±2.58	1.56±2.44	-0.07±2.11	0.64	0.00	0.02	0.03
10	0.95±1.91	0.54±1.61	-0.40±1.92	0.41	0.00	0.21	0.21
11	0.82±1.88	0.38±1.29	-0.37±1.60	0.51	0.00	0.19	0.23
12	1.70±2.35	1.05±1.87	0.82±2.06	0.57	0.00	0.35	0.40
13	1.82±2.47	1.63±2.31	-0.05±1.99	0.63	0.00	0.02	0.02
14	0.26±0.95	0.32±1.28	0.08±1.09	0.55	0.00	0.08	0.07
15	0.46±1.25	0.43±1.11	-0.02±1.21	0.46	0.00	0.02	0.02
16	2.43±2.81	1.99±2.69	-0.66±2.76	0.53	0.00	0.23	0.24
17	3.71±2.66	3.81±2.73	-0.03±2.51	0.54	0.00	0.01	0.01
18	1.23±2.25	0.83±1.66	-0.11±2.16	0.32	0.00	0.05	0.05

Item	Anchor-based approach	Distribution-based approach
1	1.13±3.03	0.51
2	1.07±3.18	0.27
3	0.44±3.21	0.36
4	0.39±3.63	0.18
5	0.52±2.80	0.36
6	0.71±2.54	0.15
7	0 （0， 0）	0.04
8	0 （0， 0）	0.08
9	0.23±2.63	0.04
10	0.21±2.38	0.20
11	0.60±1.89	0.16
12	1.28±2.72	0.60
13	0.26±2.61	0.04
14	0 （0， 0）	0.02
15	0 （0， 0）	0.01
16	0.71±2.50	0.57
17	0.07±3.38	0.05
18	0.18±2.62	0.06

Item	Anchor-based approach	Distribution-based approach
1	1.13±3.03	0.51
2	1.07±3.18	0.27
3	0.44±3.21	0.36
4	0.39±3.63	0.18
5	0.52±2.80	0.36
6	0.71±2.54	0.15
7	0 （0， 0）	0.04
8	0 （0， 0）	0.08
9	0.23±2.63	0.04
10	0.21±2.38	0.20
11	0.60±1.89	0.16
12	1.28±2.72	0.60
13	0.26±2.61	0.04
14	0 （0， 0）	0.02
15	0 （0， 0）	0.01
16	0.71±2.50	0.57
17	0.07±3.38	0.05
18	0.18±2.62	0.06

[1]	LI Zhuohang, YU Xindi, REN Jingya, SHEN Jia, DONG Suzhen, WANG Wei. Postoperative neurodevelopmental outcomes of end-to-side anastomosis for coarctation of the aorta [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(6): 753-759.
[2]	GAO Yuyan, LI Wei, WANG Shuting, KISHIMOTO Tomoko, ZHANG Ruyuan. Relationship between psychopathological symptoms and drug addiction, and mediating role of psychological distress in drug addicts [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(1): 51-59.
[3]	DONG Ran, YU Qian, TAI Rui, YANG Fu, FANG Fang. Early symptom network analysis of patients after transfer from intensive care unit [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(6): 733-740.
[4]	LIU Yuting, YU Wanqi, HONG Wen, KANG Sang, LI Xinni, DANZENG Quyang, XIAO Huoyuan, PAN Jingwei. Predictive value of Clinical Frailty Scale in long term prognosis of patients with acute myocardial infarction after in-hospital cardiac rehabilitation [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(5): 599-605.
[5]	ZHENG Mengyi, MAO Jialiang, ZOU Zhiguo, ZHANG Ruilei, ZHANG Hou, LI Shiguang. Predictive value of systemic immune inflammation index and somatic symptom scale-China in the occurrence of in-hospital major adverse cardiovascular events after first-episode of acute myocardial infarction undergoing PCI [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(3): 334-341.
[6]	YANG Ruijun, LÜ Shuhong, LIU Zhiye, ZHANG Xin, LIU Zhihao. Relationship of screen time and dietary behaviors with depressive symptoms in junior high school students in five provinces in China [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(3): 358-364.
[7]	LU Qifan, LIU Qiming, ZHOU Hongmei, CHAI Yezi, JIANG Meng, PU Jun. Effect of somatic symptoms, anxiety and depression on clinical prognosis in patients with chronic heart failure [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(9): 1153-1161.
[8]	ZHU Hanjing, YIN Hongfan, YOU Sijie, YANG Yan. Latent profile analysis of adverse effects associated with endocrine therapy in prostate cancer patients based on the theory of unpleasant symptoms [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(9): 1186-1193.
[9]	ZHOU Shuang, LU Huijie, DU Zheyi, HU Shimin, DONG Ping, JIANG Ying. Reliability and validity of the Chinese version of St Andrew′s Nutrition Screening Instrument [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(9): 1194-1200.
[10]	LIU Yanyan, YANG Tiantian, SHEN Nanping, HE Mengxue, ZHANG Hongyan. Latent profile analysis of multiple symptom distress in children and adolescents with cancer and its effect on their physical activity [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(11): 1408-1416.
[11]	LUO Xin, YUAN Chengmei. Current status of development of Chinese versions of insomnia-related scales [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(11): 1436-1444.
[12]	LIU Pengtao, ZHANG Zhiyuan, BAI Kaiping, XING Xiaoyu, ZOU Xiangyu, SUN Jie. Analysis of early clinical symptoms and surgical intervention of hemorrhagic cystitis after hematopoietic stem cell transplantation in children [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(7): 958-963.
[13]	SUN Wentao, XIE Yufeng, SHU Rong. Reliability and accuracy analysis of root coverage esthetic score [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(5): 602-608.
[14]	SHEN Hui, WU Yuejuan, ZHU Huijuan, XU Chuchen, ZHANG Li, FAN Qing. Analysis of therapeutic effect of mindfulness-based intervention on inpatients with chronic schizophrenia [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(12): 1693-1698.
[15]	WEI Shan, JI Ouyang, CHEN Zhihao, HUANG Zehui, LI Pu, FANG Junyan, LIU Yingli. Development and validation of a knowledge, attitude, belief and practice scale for safe medication in patients with chronic kidney disease [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(12): 1729-1738.